Free Trial

B. Metzler seel. Sohn & Co. Holding AG Invests $2.96 Million in MetLife, Inc. (NYSE:MET)

MetLife logo with Finance background

B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in shares of MetLife, Inc. (NYSE:MET - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 35,887 shares of the financial services provider's stock, valued at approximately $2,960,000.

Several other institutional investors and hedge funds have also modified their holdings of MET. Abacus Planning Group Inc. lifted its position in shares of MetLife by 1.0% in the third quarter. Abacus Planning Group Inc. now owns 12,301 shares of the financial services provider's stock worth $1,015,000 after buying an additional 127 shares during the last quarter. Financial Management Professionals Inc. lifted its holdings in MetLife by 2.0% in the 3rd quarter. Financial Management Professionals Inc. now owns 6,984 shares of the financial services provider's stock worth $576,000 after purchasing an additional 136 shares during the last quarter. Ameliora Wealth Management Ltd. boosted its position in MetLife by 1.7% during the third quarter. Ameliora Wealth Management Ltd. now owns 8,548 shares of the financial services provider's stock worth $705,000 after purchasing an additional 139 shares during the period. Greenleaf Trust grew its holdings in MetLife by 0.4% during the third quarter. Greenleaf Trust now owns 31,393 shares of the financial services provider's stock valued at $2,589,000 after purchasing an additional 139 shares during the last quarter. Finally, Forum Financial Management LP raised its position in shares of MetLife by 1.0% in the second quarter. Forum Financial Management LP now owns 13,729 shares of the financial services provider's stock valued at $964,000 after purchasing an additional 141 shares during the period. Institutional investors and hedge funds own 89.81% of the company's stock.

MetLife Stock Performance

NYSE:MET opened at $82.60 on Thursday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.51. The firm has a 50-day moving average price of $82.08 and a 200 day moving average price of $75.84. The firm has a market capitalization of $57.19 billion, a PE ratio of 16.65, a price-to-earnings-growth ratio of 0.75 and a beta of 1.05. MetLife, Inc. has a 12-month low of $62.14 and a 12-month high of $86.94.

MetLife Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, December 16th. Investors of record on Tuesday, November 5th will be given a dividend of $0.545 per share. The ex-dividend date is Tuesday, November 5th. This represents a $2.18 annualized dividend and a dividend yield of 2.64%. MetLife's dividend payout ratio (DPR) is presently 43.95%.

Analysts Set New Price Targets

A number of research firms recently issued reports on MET. Wells Fargo & Company raised their target price on shares of MetLife from $92.00 to $93.00 and gave the company an "overweight" rating in a research note on Tuesday, November 5th. Bank of America cut their price objective on MetLife from $99.00 to $96.00 and set a "buy" rating for the company in a research report on Thursday, August 1st. Morgan Stanley dropped their price target on MetLife from $86.00 to $85.00 and set an "overweight" rating on the stock in a research report on Monday, August 19th. TD Cowen initiated coverage on MetLife in a research report on Wednesday, October 9th. They issued a "buy" rating and a $97.00 price objective for the company. Finally, Jefferies Financial Group boosted their target price on shares of MetLife from $89.00 to $95.00 and gave the stock a "buy" rating in a research report on Friday, September 27th. Fourteen research analysts have rated the stock with a buy rating, According to data from MarketBeat, the company presently has an average rating of "Buy" and an average price target of $88.46.

Get Our Latest Stock Analysis on MetLife

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Articles

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Should you invest $1,000 in MetLife right now?

Before you consider MetLife, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MetLife wasn't on the list.

While MetLife currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines